UPDATED May 29, 2025
Discover large cap Belgian Pharmaceuticals & Biotech companies that are on the BEL20. These Pharmaceuticals & Biotech Companies are organised by Market Cap.
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
ARGX | €513.00 | -0.7% | 52.1% | €31.3b | €670.30 | PE33.5x | E26.6% | n/a | ||
UCB | €155.25 | -3.3% | 22.7% | €29.5b | €208.44 | PE27.7x | E17.3% | 0.9% | ||
TUB | €123.40 | -1.9% | 27.2% | €5.5b | €182.75 | PE61x | n/a | 0.8% | ||
HYL | €5.76 | -3.7% | -50.8% | €161.3m | €12.50 | PS16.5x | E43.1% | n/a | ||
ALEMS | €4.30 | -9.5% | -48.2% | €18.2m | n/a | PE33.3x | n/a | n/a | ||
CYAD | €0.43 | -4.8% | 42.5% | €18.0m | n/a | PS96.7x | n/a | n/a | ||
BIOS | €0.0018 | 12.5% | -90.4% | €1.2m | n/a | PE-0.2x | n/a | n/a | ||
OXUR | €0.052 | -4.7% | -94.8% | €322.6k | n/a | PE2.7x | n/a | n/a |